Nudging Parental Actions for Youth Suicide Prevention
Nudging Parental Action With A Randomized Controlled Trial of Text Messaging Intervention for Suicide Prevention
University of Texas Southwestern Medical Center
129 participants
Jun 15, 2026
INTERVENTIONAL
Conditions
Summary
The goal of the study is to determine effectiveness of a behaviorally informed text messaging intervention to help parents increase safety practices and reduce their teens' access to lethal means following a suicide-related emergency department visit.
Eligibility
Inclusion Criteria6
- Guardian must be able and willing to provide informed consent, and the participant must be able and willing to provide assent.
- Parent and adolescent willingness and ability to participate in study procedures and complete assessments at baseline, 6 weeks, and 12 weeks.
- Presentation to the ED for a suicide-related emergency, defined as suicidal ideation within the last 2 weeks or a suicide attempt within the past month.
- Adolescents aged 12-17 years during the consent.
- Access to a mobile phone with text messaging capability for the parent/legal guardian.
- Ability to communicate in English.
Exclusion Criteria6
- Absence of a legal guardian capable of providing consent.
- Parents/legal guardians without access to a mobile phone with texting capability.
- Inability to communicate in English.
- Adolescents in state custody or under legal restrictions that prevent study participation.
- Adolescents involved in the justice system in a manner that would interfere with study participation.
- Adolescents with autism spectrum disorder or intellectual development disorder needing substantial or very substantial support
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The intervention consists of thrice-weekly, behaviorally informed text messages delivered to parents over six weeks period.
Thrice-weekly messages incorporating safety precautions and evidence-based suicide risk statistics to recalibrate parental risk perception.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07383714